Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.09 -0.21 (-0.74%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 46,894,686
Open 28.48
Bid (Size) 28.11 (11)
Ask (Size) 28.12 (33)
Prev. Close 28.30
Today's Range 28.05 - 28.54
52wk Range 25.20 - 31.54
Shares Outstanding 5,606,688,356
Dividend Yield 5.84%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Sensational Growth Stocks to Buy at a Discount
These growth stocks are looking especially attractive right now. 
Via The Motley Fool
This Beaten-Down Stock Just Gave Investors More Good News: Is it a Buy?
Slowly but surely, the company's prospects are looking more attractive. 
Via The Motley Fool

Performance

YTD
-5.52%
-5.52%
1 Month
-0.88%
-0.88%
3 Month
-5.55%
-5.55%
6 Month
-0.25%
-0.25%
1 Year
-10.14%
-10.14%

More News

Read More
3 Potential Catalysts That Could Lift Pfizer Stock Before 2025
Via The Motley Fool
3 Reasons Relying on Social Security Alone Could be a Risk. And 3 Stocks to Invest in Today.
Via The Motley Fool
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
Via Benzinga
GSK Stock Crumbles As Vaccine Sales Plummet And Miss Expectations
Via Investor's Business Daily
Pfizer Earnings Top Q3 Views; Pharma Giant Guides Higher
Via Investor's Business Daily
Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review
Via Investor's Business Daily
Stocks Going Ex Dividend In November 2024
Via Talk Markets
AWKO Files Lawsuit on Behalf of Sickle Cell Patient Against Pfizer’s Subsidiary
Via Law Firm Newswire
Topics Lawsuit
Exposures Financial Legal
3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might Think
Via The Motley Fool
Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO
Via Investor's Business Daily
Nasdaq Hits Record High Ahead Of Big Tech Earnings: Fear Index Remains In 'Greed' Zone
Via Benzinga
Why Pfizer Stock Tumbled on Tuesday
Via The Motley Fool
Pfizer (PFE) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Biotech Momentum Trades For The Q4 Rally
Via Talk Markets
Tech Stocks Rise Ahead Of Key Earnings, Gold Smashes Records, Bitcoin Nears All-Time Highs: What's Driving Markets Tuesday?
Via Benzinga
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views
Via Benzinga
Pfizer Inc.’s Strong Q3 Performance: Beats Expectations With $1.06 EPS
Via Talk Markets
Pfizer Q3 Earnings: Revenue And Profit Beat On Heightened Demand For Paxlovid, Expects $10 Billion In 2024 Revenue From COVID Products
Via Benzinga
Exposures COVID-19
US Stocks Likely To Open Weaker As Investors Eye Alphabet, AMD And Pfizer Earnings: Expert Says Won't Be 'Surprised' If Earnings Exceed Wall Street Expectations
Via Benzinga
Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance
From Pfizer Inc.
Via Business Wire
Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Pfizer, Alphabet And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.